Novartis AG (NOVNN.MX)

1,719.29 0.00 (0.00%) At close: 09:10AM CST

Novartis AG

Lichtstrasse 35
Basel 4056
Switzerland
41 61 324 1111
https://www.novartis.com

Sector(s): 
Industry: 
Full-time employees: 76,057

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Vasant Narasimhan M.D.	Chief Executive Officer	147.3M	N/A	1976
Mr. Harry Kirsch	Chief Financial Officer	73.33M	N/A	1965
Mr. Victor Bulto	President of US	60.28M	N/A	1978
Dr. Patrick Horber M.D.	President of International	134.4M	N/A	1970
Dr. Steffen Lang Ph.D.	President of Operations	42.96M	N/A	1967
Paul Penepent	Head of Group Financial Reporting and Accounting	N/A	N/A	N/A
Ms. Sloan Simpson	Global Head of Investor Relations	N/A	N/A	N/A
Dr. Klaus Moosmayer Ph.D.	Chief Ethics, Risk & Compliance Officer	28.56M	N/A	1968
Ms. Karen L. Hale	Chief Legal Officer	43.08M	N/A	1968
Dr. Robert Kowalski Pharm.D.	Chief People & Organization Officer	38.63M	N/A	1968

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in MXN.

Description

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Corporate governance

Novartis AG’s ISS governance QualityScore as of 1 June 2024 is 1. The pillar scores are Audit: 1; Board: 2; Shareholder rights: 1; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.